Ultrasound has made significant advancements in reproductive medicine, especially infertility of a female cause. It is a useful tool in the diagnosis and management of various disorders. Transvaginal ultrasonography in particular plays a vital role in infertility treatment as it allows for evaluation of normal and stimulated ovarian cycles, aspiration of follicles, and subse quent transfer of embryos. The use of color Doppler permits visualization of endometrial and intraovarian vessels, facilitating an understanding of normal and abnormal physiology of the uterus and ovaries. This article reviews a variety of case scenarios regarding female infertility that may be encountered in the practice of reproductive endocrinology. Ovarian causes such as polycystic ovarian syndrome, luteinized unruptured follicle, luteal phase defect, premature ovarian failure, and endometriosis, are discussed together with tubal and uterine causes of infertility. By using illustrative images, the reader will be able to correlate findings on Bmode, color Doppler and 3D ultrasound with various causes of female infertility.
INTRODUCTION
Infertility is defined as failure of a couple to achieve preg nancy after 12 months of unprotected intercourse. It can have a significant psychological impact on those afflicted. Fortunately, many couples have favorable outcomes and end up conceiving without major interventions. For those who are not successful, there have been significant advancements in assisted reproductive technology (ART). Of the new methods, ultrasound has shown tremendous potential in the diagnosis and management of female infertility.
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Transvaginal ultrasound is advantageous to trans abdominal because it allows for better spatial resolution and avoids the need for a full urinary bladder. Twodimensional (2D) Bmode ultrasound depicts sagittal and transverse planes. Threedimensional (3D) ultrasound allows for sagittal, transverse, and coronal views giving a more detailed image of the pelvic organs. The addition of color Doppler via transvaginal probes allows visualization of the miniscule intraovarian and endometrial vessels. Deviations from normal structure and function can be detected with these modern methods of imaging.
There are numerous etiologies which factor into making a woman subfertile or infertile. Ovarian causes include poly cystic ovary syndrome (PCOS), premature ovarian failure (POF), endometrioma, luteinized unruptured follicle (LUF) and luteal phase defect (LPD). Tubal factor infertility is most often associated with chronic pelvic inflammatory disease (PID). Uterine causes include submucosal fibroids, congenital Mullerian anomalies, such as septate uterus, endometrial polyps and intrauterine adhesions. The recent advances in ultrasound technique allow for the accurate diagnosis of these disorders. For some of these conditions, e.g. premature ovarian failure, ultrasonography has shown to be useful in formulating a treatment plan and predicting prognosis. The ten cases aforementioned are discussed here; ultrasound images are correlated with various clinical and laboratory findings to assist the reader in evaluation and management of female infertility.
CASE REPORTS

Case 1
A 32yearold primary infertile female presents complaining of irregular menstrual periods since menarche which began at age 13. Her last menstrual period was three months ago. She also complains of acne and hair on her face, chin and abdomen. She denies changes in her voice, changes in vision, headaches and nipple discharge. Her past medical history is noncontributory. She states, she is not taking any medications and she is sexually active only with her husband. She is married for 5 years and has never conceived. On physical examination, she is markedly obese. Her BMI measures 32. She has visible facial and abdominal hair. On pelvic examination, the uterus is normal size and no adnexal masses are noted.
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Case 2
A 39yearold primary infertile female presents with complaints of irregular menstrual bleeding for the past two years. She states that her periods have always been regular since menarche at age 14 but for the past two years, her cycles are usually prolonged and her periods are unpredictable. She denies any physical complaints. She is married for three years and her husband has two children from his previous marriage. On physical exam, she is afebrile and in no acute distress. Her vagina, cervix and uterus are within normal limits, and no adnexal masses are noted. Three months ago she started measuring her basal body temperature, which was typically biphasic. Elevation of the basal body temperature was noted on day 14 and remained high for the rest of her menstrual cycle.
Today is day 21 of the menstrual cycle; you decide to perform pelvic ultrasound.
A pelvic ultrasound reveals a 2.8 × 2.6 cm cystic structure on the left ovary (Figs 2A and B) and a thickened secretory transformed endometrium. Color Doppler depicts peripheral Note normal size uterus and enlarged ovary on the left
Fig. 1C: Color Doppler image of the ovary indicates increased intraovarian perfusion
Laboratory studies revealed negative betahCG, normal TSH and normal prolactin. Her FSH on day 3 of the menstrual cycle was normal; however, her LH was elevated. Her free testosterone was also elevated. Pelvic ultrasound was performed and findings are presented on Figures 1A to C. vessels with moderate to high vascular impedance (RI 0.72, PI 1.92). You decide to assess serum progesterone level. The result was normal for luteal phase and indicated ovulatory cycle.
Case 3
A 38yearold G3P2012 patient presents with complaints of shortened menstrual cycles for the past year. Her history is significant for one spontaneous abortion 8 months ago at 7 weeks gestation. She states that her periods used to be regular since menarche at age 13 but for the past year, her cycles are short and occur every 20 to 23 days. She denies any physical complaints. She is married for seven years and has two children (5 and 3 years). On physical examination, she is afebrile and in no acute distress. Her pelvic examination was within normal limits. Today is the 20th day of her menstrual cycle; you decide to order serum progesterone level and perform pelvic ultrasound.
A pelvic ultrasound reveals a normal size ovary with discrete luteal conversion blood flow signals (Fig. 3) . Moderate impedance blood flow signals with resistive index of 0.54 were detected. Serum progesterone was significantly decreased (1.8 ng/ml), compared to normal values between 4.4 to 28.0 ng/ml.
Case 4
A 27yearold nulliparous primary infertile patient presents to your clinic with symptoms of amenorrhea and hot flashes. Her last menstrual period was 6 months ago. Her menarche was at 12 years, and she has had developed secondary sexual characteristics appropriately. Her menstrual cycles were always irregular, and she was taking oral contraception for 8 years (since her first coitus at age of 17). Thereafter her menstrual cycles were irregular and she experienced estrogen deficiency symptoms (vaginal dryness, hot flashes and dyspareunia). Her serum gonadotropin concentrations were found to be elevated (FSH 40 mIU/ml and LH 55 mIU/ml). Her pelvic ultrasound images are displayed on Figures 4A to C. 
Case 6
A 29yearold primary infertile patient presents to your office for infertility assessment. Her history is significant for STD and two episodes of PID. Age of first intercourse was 14 years, onset of menarche at age 13. Her last menstrual period was seven days ago and was normal. She complains of chronic pelvic pain. Her past medical history (other than PID) is nonsignificant. Her vital signs are within normal limits. Her physical examination is significant for bilateral adnexal fullness. Figures 6A and B demonstrate her pelvic ultrasound findings.
Case 7
A 32yearold (G3P2012) woman presents to your office because of secondary amenorrhea. The patient's menstrual cycles had previously been normal (28/5) . Her history is significant for an incomplete abortion 6 months ago. Five months ago she underwent a dilatation and curettage (D&C) for heavy bleeding associated with presence of residual products of conception. Her menarche was at 13 years. General physical and pelvic examinations were normal. There are no symptoms suggestive of ovarian failure (patient does not complain of hot flashes, insomnia, and similar menopausal symptoms). There is no evidence of galactorrhea.
Case 8
A 32yearold female (G3P0030) presents to your office with history of recurrent pregnancy loss at 8, 9 and 12 weeks of gestation. She has had 3 miscarriages within the past 4 years. She is in a monogamous relationship with her husband and she wants to have a child. Her menstrual cycles are regular (28/6 days). Her history is significant for dysmenorrhea. Onset of menarche was at 12 years, age of first intercourse was 17 years, with no history of sexually trans mitted diseases. She is currently not on any medications. Her vital signs and her physical examination were normal. Figure 8 illustrates her 3D ultrasound findings.
Case 9
A 38yearold G2P1011 female complains of menorrhagia for the past 1.5 years. Her periods occur every 28 days and used to last for 5 days, but are now lasting up to 10 to 14 days at a time. One year ago she was diagnosed with spontaneous abortion at 8 weeks. On physical examination, she is visibly pale. Her vital signs are within normal limits. Her last menstrual period was 3 weeks ago. On pelvic examination, the uterus is enlarged, and no adnexal masses are palpated. Laboratory studies revealed negative betahCG. Her hemoglobin level is 9.0 gm/dl and her hematocrit is 22%. She is married for 8 years and wants to get pregnant. Transvaginal ultrasound showed irregular contours of the uterine cavity and an order was placed for saline infusion sonography (SIS). Saline infusion sonography findings are demonstrated in Figures 9A and B . 
Case 10
A 29yearold primary infertile patient is getting prepared for her IVF/ET cycle. Recently she noticed that her periods are prolonged with evidence of 3 to 4 days spotting. Her past medical history is nonsignificant. Her general physical and pelvic examinations were within the normal limits. Her Pap smear and Gonorrhea and Chlamydia cultures were normal. Her husband was diagnosed with oligoasthenozoospermia. Pelvic ultrasound was performed and revealed thickened and hyperechogenic endometrium in early postmenstrual phase. An order was placed for SIS and results are shown on Figure 10 .
DISCUSSION
Case 1: Polycystic Ovary Syndrome
Polycystic ovary syndrome (PCOS) is diagnosed based on two out of the three Rotterdam criteria: oligomenorrhea and/ or anovulation, hyperandrogenism, and polycystic ovaries on ultrasound. 1 Our patient presents with oligomenorrhea (irregular menstrual periods) and hyperandrogenism (acne and male pattern hair distribution). We must rule out pregnancy in any woman of reproductive age that is having menstrual irregularities (via betahCG). Serum follicle stimulating hormone (FSH) should be measured to rule out ovarian insufficiency. In patients with PCOS, FSH will be normal but luteinizing hormone (LH) will be elevated with an LH : FSH ratio usually greater than 2.
Transvaginal ultrasound is advantageous to trans abdominal because it avoids the need for a full bladder and eliminates the difficulty of visualizing structures in the obese patient. Pelvic ultrasound in this patient demonstrated enlarged ovaries and an increased ovarian volume of approximately 15 cc bilaterally (see Figs 1A and B) . Criteria for diagnosing polycystic ovaries on ultrasound is an ovarian volume >10 cc or more than 10 follicles measuring between 2 and 9 mm. 1 Color Doppler studies in Figure 1C show changes in the ovarian vasculature which are associated with tonic hyper secretion of LH during the follicular phase of the menstrual cycle. There are higher uterine pulsatility index (PI) values; PI is a measure of the variability of blood velocity in a ves sel. The higher PI values are possibly due to direct androgen vasoconstriction in arterial vessel walls, thereby reducing uterine perfusion. This has been cited as a possible cause of failed blastocyst implantation, increasing the incidence of miscarriages in PCOS patients. 2 The ovaries are usually enlarged in PCOS patients; however, they can also be of normal size. Visualization of the stromal area can provide a diagnostic clue to differentiate PCOS from the multifolli cular ovary; it is hypertrophic in PCOS whereas it is not increased in size in multifollicular ovaries. 3 The presence of multiple ovarian cysts resembling PCOS on ultrasound have been found in 92% of women with idiopathic hirsutism, 87% with oligomenorrhea and 82% in both premenopausal type 2 diabetics and congenital adrenal hyperplasia. 46 Therefore, it is important to rule out these disorders in a woman presenting with symptoms of PCOS.
Other diseases that can cause anovulation, oligomenorrhea and hyperandrogenism must be excluded before diagnosing PCOS. The differential diagnosis of oligomenorrhea can be narrowed by ordering TSH to rule out thyroid dys function and prolactin to rule out hyperprolactinemia. All women with possible PCOS should be screened for nonclassical congenital adrenal hyperplasia (NCCAH) with 17hydroxyprogesterone levels. 7 Androgensecreting ovarian/adrenal tumors and ovarian hyperthecosis can mimic PCOS with hirsutism and acne. However, pertinent clues from the history, such as age, timing and severity of symptoms and presence of virilization help distinguish the two. Women with PCOS are classically premenopausal and have a history of irregular periods since menarche whereas women with androgensecreting tumors are usually postmenopausal and present with recent, sudden onset of hirsutism and virilization (frontal balding, severe acne, clitoromegaly, increased muscle mass or voice deepening). 8 Women with PCOS are at increased risk for diabetes, cardiovascular disease, infertility, endometrial cancer, mood disorders and sleep apnea. Obesity and insulin resistance are highly prevalent among women with PCOS, therefore they are advised to control weight with diet and exercise. In addition, blood pressure, body mass index (BMI), fasting lipid panel and a 2 hour oral glucose tolerance test (OGTT) should be obtained at the initial visit. 9 Patients with a normal glucose tolerance test should be rescreened at least once every two years and those with an abnormal test should be screened annually to monitor development of type 2 diabetes. Women with PCOS are frequently unable to conceive due to their anovulatory menstrual cycle; serum progesterone can be measured to assess whether or not ovulation has occurred. If not, clomiphene citrate can be used to induce ovulation. Ultrasound can be used to monitor the status of ovulation. Color Doppler in Figure 1C demonstrates prominent intraovarian vascular network, which is considered high risk for ovulation induction as there is an increased risk of ovarian hyperstimulation syndrome (OHSS). Ovarian hyperstimulation syndrome is a potentially lifethreatening complication that presents with massive ovarian enlargement and thirdspacing of intravascular fluid leading to renal failure, hypovolemic shock, thromboembolism, acute respiratory distress syndrome, and death. 10, 11 The proposed mechanism is a possible increased delivery of gonadotropins due to increased blood flow, leading to an excessive ovarian response. Evaluation of the vasculature via 3D power Doppler may be helpful to learn more about OHSS. 12 The unopposed estrogen due to anovulatory cycle places women with PCOS at increased risk of endometrial cancer. Routine use of transvaginal ultrasound to screen for cancer is not recommended for premenopausal women. 13 Endometrial hyperplasia is prevented with a progestincontaining oral contraceptive which also alleviates acne and regulates the menstrual cycle.
14 Finally, women with PCOS should be screened for depression, anxiety and sleep apnea. 15 Firstline treatment is weight reduction via diet and exercise as a lower BMI is associated with an improved likelihood of ovulation and conception and an overall improved quality of life. Poly cystic ovary syndrome is progressive; therefore, the use of ultrasound with color Doppler can play a significant role in treatment and followup.
Case 2: Luteinized Unruptured Follicle
Luteinized unruptured follicle (LUF) can occur when there are presumptive signs of ovulation without release of an oocyte. The biphasic basal body temperature and normal serum progesterone level exclude anovulatory cycle as the cause of our patient's irregular bleeding. Ultrasound can also be used to confirm ovulation by measurement of mean follicular diameter, detection of follicular collapse, visualization of the corpus luteum and extraovarian signs (thickened endometrium and free fluid in the cul desac). The estimated frequency of LUF syndrome is between 6 and 47%. 12 A precise etiology has yet to be established, but numerous theories have been proposed; these include impairment of the midcycle LH surge, absence of preovulatory progesterone rise, abnormalities of prostaglandin synthesis and an intrinsic oocyte abnormality. Micu et al conducted a prospective study which showed that women receiving nonsteroidal antiinflammatory drugs (NSAIDs) for rheumatic disease had a greater incidence of the LUF syndrome as compared to nonexposed women (35.6 vs 3.4%). 16 Etoricoxib, a COX2 inhibitor, was found to have the most potent effect (75% of all LUF cases) while diclofenac was less significant (15%). Interestingly, there was a much higher frequency of LUF syndrome in patients with inactive rheumatic disease compared with active disease. 16 There is an association between LUF syndrome and unexplained infertility, chronic pelvic infections and endometriosis. Affected patients are advised to undergo follicular assessment via transvaginal ultrasound. The resistive index (RI) is a measure of blood flow impedance and exhibits normal variations throughout the menstrual cycle. In normal patients, preovulatory RI values are moderate to high (0.56 ± 0.06) and drop after the LH surge (0.44 ± 0.04).
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However, multiple studies have shown that RI values in LUF syndrome patients remain high throughout both follicular and luteal phases. In addition, endometrial dating is normal in these patients. 17, 18 Perifollicular blood flow around the time of ovulation seems to be regulated by LH and the decrease in blood flow velocity due to a persistently high vascular impedance is diagnostic of LUF syndrome. 19 Two types of LUF syndrome have been identified: mature follicle LUF and premature luteinization LUF. In the first type, the release of an oocyte was not demonstrated following follicle maturation (serum estradiol reached 200 pg/ml while serum progesterone remained less than 2.5 ng/ml). In the second type the serum progesterone increased above 2.5 ng/ml before follicular maturation was attained. Human chorionic gonadotropin (hCG) can be used alone or in combination with human menopausal gonadotropin (hMG) to correct mature follicle LUF, while gonadotropins can be used to speed up the maturation process in premature luteinization LUF. 20 If gonadotropin therapy is ineffective, the patient's next option is in vitro fertilization and embryo transfer (IVFET).
Case 3: Luteal Phase Defect
A patient who presents with shortened menstrual cycles and firsttrimester pregnancy loss should be evaluated for luteal phase defect (LPD). Initial diagnostic studies should include a serum progesterone level (normal = 4.4 to 28.0 ng/ml) and pelvic ultrasound during the midluteal phase (day 2021 of menstrual cycle). Once a thickened endometrium is identified on ultrasound, endometrial biopsy may be performed to confirm dating. Luteal phase defect (also known as short luteal phase, luteal insufficiency, inadequate luteal phase and luteal phase deficiency) is characterized by lack of progesterone, a luteal phase of the menstrual cycle shorter than 11 days and an outofphase endometrium by 2 or more days. The exact etiology is unclear; however the cause may be an intrinsic defect in the formation of the corpus luteum or external factors such as strenuous exercise or ovulation stimulating drugs. 12 The corpus luteum plays a significant role in the woman's reproductive cycle, especially in early pregnancy. Once ovulation has occurred, blood vessels from the theca layer invade the ruptured follicle beginning the formation of the corpus luteum. Luteal cells produce more LH receptors and through a positive feedback mechanism, amplify the production of progesterone. This amplification continues until the midluteal phase, which is characterized by peak values of blood LH, progesterone and a low resistance index (RI) in corpus luteum blood vessels. As was mentioned previously, women with regular ovulatory cycles have variation in their ovarian RI values depending on the phase of menstrual cycle. During the follicular phase, a moderate to high RI (mean 0.56 ± 0.06) can be obtained at the rim of the follicle with a significant decline on the day of the LH peak (0.44 ± 0.04) with the nadir occurring at midluteal phase (0.42 ± 0.06). In women with LPD, there is no change in the intraovarian RI during the transition from follicular (RI 0.56 ± 0.06) to luteal (RI 0.56 ± 0.04) phases, and also shows no changes between early, middle, and late luteal phases. 12, 21 Luteal phase defect constitutes one of the possible endocrine factors involved in recurrent pregnancy loss (RPL). There are a number of contributors that could poten tially cause miscarriage such as impaired corpus luteum formation and decreased endometrial vascularity. A study by Glock et al demonstrated that decreasing corpus luteum volume before 8 weeks gestation was associated with increased risk of pregnancy loss. They used color and pulsed Doppler to determine the dominant ovary (one containing corpus luteum). The dominant ovary showed low impedance to blood flow with RI values between 0.39 and 0.49 while the contralateral nondominant ovary had RI values between 0.69 to 1.0. Patients with ovarian RI values of 0.74 from a dominant ovary and 0.79 in nondominant ovary experienced pregnancy loss. 22 Glock and Brumsted also correlated intra ovarian blood flow with values of progesterone throughout the menstrual cycle. Mean progesterone levels were significantly lower for patients with LPD as compared to controls.
23
A decline in endometrial vascularity is also associated with miscarriage as shown in a study by Chen et al. 24 They compared the endometrial and subendometrial vascularity of healthy, fertile women and those with recurrent miscarriages. Using 3D ultrasound and power Doppler angiography, they found that the endometrial and subendometrial vascularization index, flow index and vascularization flow index were greatly reduced in the group with unexplained recurrent miscarriage. 24 Luteal phase defect is a commonly encountered problem when using assisted reproductive technology (ART). After ovulation induction, supporting the luteal phase with proges terone or hCG has shown to improve pregnancy outcomes. 25 Some authors found vaginal progesterone to be the most effica cious with the least side effects while hCG was asso ciated with the risk of ovarian hyperstimulation. 26 In some instances, the LPD associated with controlled ovarian hyper stimulation (COH) for IVF was not correctable. For these cases they recommended freezing of all embryos and deferring transfer to an artificial estrogen progesterone or natural cycle.
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Case 4: Premature Ovarian Failure
Premature ovarian failure (POF), also known as primary ovarian insufficiency, is the cessation of menses for at least 4 months before the age of 40 years. 27 Spontaneous POF occurs at a rate of 1 in 10,000 by age 20, 1 in 1,000 by age 30, and 1 in 100 by age 40. 28 Patients may present with menopauselike symptoms such as oligomenorrhea/ amenorrhea, vaginal dryness, hot flashes and dyspareunia which are characteristic of an estrogen deficiency state. Any woman <40 years old presenting with >3 consecutive months of menstrual irregularity warrants an evaluation for POF. 29 Other causes of menstrual irregularity such as pregnancy and hyperprolactinemia should be ruled out. Definitive diagnosis is made via measurement of serum estradiol and serum FSH on day 3 of the menstrual cycle. An estradiol level of <30 pg/ml and FSH >3040 IU/l in the presence of clinical symptoms is highly suggestive of POF. However, these values can be closer to normal if the patient is experiencing oligomenorrhea. Transvaginal ultrasound can assist in diagnosis by demonstrating a thin and hyperechogenic endometrium as seen in postmeno pausal women (see Fig. 4A ). The cutoff value for endo metrial thickness is 5 mm in patients with menopause.
There is an inverse relationship between uterine/ovarian size and the time since menopause; the uterus and ovaries will significantly decrease in size as the duration of menopause increases. 30 Figure 4B demonstrates a diminished ovarian volume and absence of growing follicles, while Figure 4C exhibits decreased intraovarian blood flow. After diagnosing POF, transvaginal ultrasound can also be used to assess follicle count and function. Hubayter et al. injected a single dose of 300 IU hrFSH to 95 women with POF and 42 regularly menstruating controls. Antral follicles >3 mm were detected in 73% of patients on pelvic ultrasound and both serum estradiol and progesterone levels correlated with follicular diameter. Estradiol concentration did not significantly increase in patients with POF as compared to controls. However, the evidence of progesterone secretion by larger follicles (>8 mm) suggests that luteinization is the main contributing factor to ovarian dysfunction in women with POF. 31 Almost 90% of POF cases are idiopathic. 27 Known causes can be classified as genetic, autoimmune, or environ mental. Two common genetic causes are Turner syndrome and Fragile X syndrome premutation. Turner syndrome is characterized by 'streak' ovaries containing connective tissue and atretic follicles. 32 If a patient presents with absent pubertal development, primary amenorrhea, and morpho logical characteristics of Turner syndrome (short stature, shield chest), karyotype is warranted. Aside from the monosomy resulting in Turner syndrome, there are various X deletions, duplications, and translocations that cause POF. Xq13 to Xq26, excluding Xq22, have been implicated as the region responsible for ovarian development and function. 33 The phenotype of Fragile X syndrome depends on the number of trinucleotide repeats in the FMR1 gene. Alleles with <40 CGG repeats are normal, 55 to 200 are 'premutations' and >200 are full mutations. The full mutation involves methylation of the gene and no subsequent protein product; however the premutation has decreased protein but elevated levels of messenger RNA (mRNA). Since the premutation variant is the only one associated with POF, it is possible that the excess mRNA acts as a toxin.
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Other genetic causes implicated in POF are galactosemia and autosomal dominant premature ovarian failure. The hypo gonadism of galactosemia is thought to be due to the toxic effects of galactose metabolites. Patients who are heterozygous for the mutation do not experience POF. 37, 38 A study by Kasippillai et al identified a heterozygous nonsense mutation with autosomal dominant inheritance when they evaluated a family with 9 women who developed menopause at age 30 in consecutive generations. 39 Premature ovarian failure has an autoimmune basis in a specific subset of patients. At the time of diagnosis, women should undergo testing for serum antiadrenal and anti21 hydroxylase antibodies as an estimated 3% will have con current autoimmune adrenal insufficiency. 40 Autoimmune oophoritis may be part of a polyglandular autoimmune syn drome, so it is imperative to screen for other conditions, espe cially adrenal insufficiency and hypothyroidism. 41 Serum anti ovarian antibody testing has poor predictive value and ovarian biopsy is not recommended.
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Chemotherapy, radiation and surgery are implicated as environmental causes of POF. Both primordial and maturing follicles are decreased in the ovaries of women receiving chemotherapy. 44, 45 Patients frequently develop amenorrhea and menstruate upon cessation of treatment. 46, 47 In contrast to chemotherapy, radiation is directly toxic to oocytes and is age and dosedependent. 48 Another iatrogenic cause of POF is surgery; aside from oophorectomy, hysterectomy is also associated with earlier menopause possibly due to damage of ovarian blood supply. 49 Treatment goals in patients with POF are alleviation of physical and emotional discomfort and prevention of compli cations. Estrogenprogestin hormone replacement therapy (HRT) is recommended to prevent osteoporosis and offer relief from vasomotor symptoms and vaginal dryness. 50, 51 Pre menopausal HRT should continue until the natural age of menopause at approximately age 50. 52 Women with POF who desire fertility are candidates for IVF with oocyte donation; the cumulative chance of achieving pregnancy after 3 cycles is up to 90%. 53 Those with an auto immune basis may benefit from immunosuppression as a method of ovulation induction; however, this treatment runs the risk of iatrogenic Cushing's syndrome.
54
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Intermittent resumption of ovarian function is not uncommon; some women continue to menstruate and even retain fertility. Bidet et al found that 86/358 (24%) of women with POF exhibited signs of continued ovarian function and 15 (4.4%) had spontaneous pregnancies. Out of the 21 spontaneous pregnancies, 16 were viable. Factors predictive of ovarian function were a positive family history of POF, secondary amenorrhea, presence of follicles at ultrasound, and inhibin B and estradiol levels. Nonpredictive factors included association with an autoimmune disease, anti mullerian hormone level, the presence of follicles on biopsy and genetic abnormalities. 55 As exhibited in this study, ultrasound is a superior tool not only for diagnosis, but also for predicting prognosis in women with POF.
Case 5: Ovarian Endometrioma
A premenopausal woman presenting with dysmenorrhea and bilateral adnexal masses raises strong suspicion for endometriosis. Endometrioma is a mass of ectopic endo metrial tissue that grows in the ovary. The etiology is imprecise although the current hypothesis suggests a retrograde flow of menstrual blood with subsequent depo sition on the ovaries. Ovarioscopy and microbiopsy have demonstrated that endometriomas are formed by invagination of the ovarian cortex which already contains active implants. 56 A patient with endometriosis presents with chronic pelvic pain of various types depending on the location of ectopic tissue: dysmenorrhea (pain with menstruation), dyspareunia (pain with intercourse) and/or dyschezia (pain with defecation). Ultrasound plays a vital role in the assessment of adnexal masses. Sonographic findings suggestive of endometrioma include a 'ground glass' appearance in a thick walled cyst (unilocular or multilocular) and homogenous low to medium level echoes ( Fig. 5A) . Demographics become very useful as these findings apply to premenopausal women. On the other hand, a 'ground glass' appearance in a postmenopausal woman warrants evaluation for malignancy. 57 Color Doppler allows for visualization of vascularity within an endometrioma (see Fig. 5B ) and can be used to confirm diagnoses after initial evaluation. Our patient exhibits moderate to high vascular impedance as demonstrated in Figure 5C . Impairment in uterine artery blood flow has been shown to affect fertility in patients with endometriosis. Using transvaginal ultrasound with Color Doppler, Porpora et al found significant RI alterations (>0.8) in women with ovarian endometriomas. At followup three months after laparoscopic surgery, there was improvement in uterine artery flow and subsequently higher pregnancy rates. 58 CA 125 is a tumor marker that may be elevated in a wide array of gynecological and nongynecological conditions. Though it is not specific for endometriosis, measuring its levels can help stage the severity. Concentrations >100 IU/ml are associated with peritoneal disease, adhesions and/or ruptured endometrioma. 59 Another finding indicative of severe disease is the presence of 'kissing ovaries' on ultrasound, i.e. ovaries so massive that they practically touch or 'kiss'. 60 Endometriosis can be associated with adenomyosis, which is characterized by the ingrowing of endometrium into the myometrium. It can present with pelvic pain, heavy menstrual bleeding, infertility, or it can be asymptomatic. Patients with adenomyosis have a diffusely enlarged uterus with a heterogenous myometrium containing multiple small cysts (see Fig. 5D ). Color Doppler may demonstrate increased vascularity. Transvaginal ultrasound detects this condition with a sensitivity and specificity of 80 and 50% respectively. 61 Definitive diagnosis and treatment of ovarian endo metrioma is laparoscopic removal via cystectomy. Specifically, excision of the cyst wall is associated with lower rates of the following: recurrence, dysmenorrhea, dyspareunia, non men strual pelvic pain and need for further surgery. It is also associated with increased rates of spontaneous pregnancy. 62 Following surgery, longterm use of combined oral contraceptives has also shown to prevent recurrence. 63 For women who wish to undergo IVF, surgical excision is not always recommended due to concern of decreased ovarian function. Endometriomas are only removed if the patient is in pain, if there is a complex or solid appearance of the ovarian endometrioma suggestive of malignancy, or if oocyte retrieval is hindered. 64 Unfortunately women with severe endometriosis (stage III/IV) continue to experience poor embryo implantation and pregnancy rates.
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Case 6: Tubal Cause of Infertility
Pelvic inflammatory disease (PID) is an infection of the female genital tract and can involve the uterus, fallopian tubes and/or ovaries. It is associated with sexually transmitted infections, especially Neisseria gonorrhoeae and Chlamydia trachomatis, but can be polymicrobial. Symptoms that should prompt clinical evaluation include a foulsmelling vaginal discharge, postcoital bleeding and urinary frequency, while fever and pelvic pain may be absent. 66 It is imperative to diagnose and appropriately treat PID to prevent longterm complications such as chronic pelvic pain, ectopic pregnancy and infertility. Our patient's history of multiple STD's and PID in the setting of chronic pelvic pain raises suspicion for hydrosalpinx. Hysterosalpingography (HSG) is an appropriate initial test to assess for tubal patency. Traditional HSG involves Xrays and it should only be done in the follicular phase.
Ultrasonography can also be used to assess fallopian tubes without exposing the oocytes to radiation. Bmode, color Doppler and 3D hysterocontrastsalpingography (Hy CoSy) are safe and efficacious methods for evaluation of fallopian tube patency without exposure to contrast dyes or radiation. 12 Threedimensional technique offers the possibility of simultaneous presentation of the uterine cavity and the corresponding tube. Normal, healthy fallopian tubes are usually not visualized by ultrasound unless they contain fluid. 'Thick tubal walls' with fluid in the lumen are a sensitive and specific finding of acute PID. 67 Postinflammatory scarring of the fallopian tubes can cause fusion of the fimbriae, impeding drainage of fluid into the peritoneum resulting in a condition called hydrosalpinx. Ultrasound will show fluid filled tubes with thin walls and incomplete septations (see Fig. 6A ). There are discrete vascularization signals at the periphery of the fallopian tubes; however, there is no blood flow within the incomplete septation (see Fig. 6B ). Some women with hydrosalpinx are asymptomatic and may present only with infertility. Zhu et al proposed decreased nerve fibers in the isthmus causing decreased motility as the mechanism behind tubal factor infertility. 68 Treatment options are surgery and/or IVFET. The presence of hydrosalpinx during IVFET has lower rates of pregnancy and implantation and a higher rate of pregnancy loss. There may be direct embryotoxicity, decreased endometrial recep tivity or a mechanical mechanism where tubal fluid flushes out the embryo. 69, 70 Tubal occlusion via the sterilization procedure Essure may be an effective option to manage hydrosalpinx prior to IVFET. 71 For surgical management, laparoscopy can help predict the prognosis of doing a bilateral salpingectomy vs neosalpingostomy. Chanelles et al demonstrated that patients with at least one functioning tube have higher cumulative pregnancy rates than patients undergoing IVF after bilateral salpingectomy (63.3% vs 50% respectively). 72 They also showed that conservative neosalpingostomy had a spontaneous pregnancy rate of 30.04%.
Case 7: Intrauterine Adhesions (Asherman Syndrome)
The majority of patients with intrauterine adhesions (synechiae) have some degree of trauma, resulting in fibrous scar tissue within the uterine cavity. Ninety percent of cases are related to curettage for missed or incomplete abortion, postpartum hemorrhage, or retained products of conception. 73 Patients usually present with infertility as their chief complaint; however, they can also have amenorrhea, cyclic pelvic pain and/or recurrent miscarriages. Amenorrhea due to the presence of adhesions is termed Asherman syndrome. Pregnancy should be ruled out in any woman of repro ductive age presenting with secondary amenorrhea. If patient is not pregnant, the physician should conduct a progesterone withdrawal test to assess for ovulatory function. Bleeding following the progesterone challenge indicates anovulatory cycle. If progesterone withdrawal test is negative, estrogen progesterone sequential test is indicated. If that is negative, serum FSH, LH and estradiol levels should be measured to detect the presence of ovarian function, which is intact in patients with Asherman syndrome. Transvaginal ultraso nography can have a very high sensitivity (8090%) with an experienced sonographer. 74 Intrauterine adhesions are visualized as irregular echogenic 'cystlike' areas in a normal size uterus. Furthermore, there is difficulty delineating the endometrium (Fig. 7) . 75 Other diagnostic methods include sonohysterogram and hysterosalpingogram (HSG) which are shown to have equal sensitivities. 76 Hysteroscopy is the gold standard for diagnosis of intrauterine adhesions as it allows for concurrent treatment with minimal trauma to the surrounding endometrium. 77 Ultrasonography is not the ideal diagnostic modality, however it can be useful in cases when hysteroscopy is difficult, e.g. cervical obstruction. Transabdominal ultra sound guidance during resection of synechiae has been shown to have lower rates of uterine perforation. It is also less expensive than laparoscopyguided hysteroscopy. 78 Further more, transvaginal ultrasound can help to predict prognosis postoperatively: women with a welldeveloped endo metrial 'stripe' lining resumed menses after surgical resection, whereas women with a minimal lining did not resume menses.
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Case 8: Septate Uterus
Septate uterus is a congenital anomaly in which there is a dividing septum within an otherwise normally shaped uterus, creating two endometrial cavities. It has a 0.5% prevalence and is classified as a Type V mullerian anomaly by the American Fertility Society classification system. 80 The septate uterus originates from failure of midline septal regression after complete fusion of the mullerian ducts. It can range from a partial midline septation to complete longi tudinal septation extending to the internal os. Compared to other congenital anomalies, it has the highest incidence of reproductive difficulties. Conception and implantation are not affected, as women with uterine anomalies have similar pregnancy rates as their normal counterparts. 81 However, they have a heightened risk of bad outcomes; complications include spontaneous abortion (21%44%) and preterm delivery DSJUOG difficulty conceiving and enlarged uterus are all pertinent of uterine cause of infertility. Leiomyomas have varying appearance on ultrasound depending on their composition of smooth muscle and con nective tissue. Compared to hysteroscopy as gold standard of diagnosis, saline infusion sonohysterography (SIS) has been shown to be a lowcost, less invasive and effective screening method.
91 Figure 9A illustrates the round lesion protruding from the endometrium into the uterine cavity. Addition of color Doppler shows multiple vessels within the fibroid (see Fig. 9B ). The greater vascularity of this lesion allows it to be differentiated from an endometrial polyp, which typically has a solitary feeding vessel within a stalk. 92 As leiomyomas enlarge, they may outgrow their blood supply leading to ischemia which is visible as calcific degeneration. This poorly vascularized environment is not adequate to support the fertilized ovum. 12 Color Doppler will show higher vascular impedance in submucosal fibroids due to the presence of myometrial tissue. Furthermore, centrally located vessels in a fibroid have lower RI values than peripheral vessels and can be mistaken for malignancy. 93 There are various proposed mechanisms that lead to subfertility and infertility in the patient with submucosal and intracavitary fibroids. These tumors express angiogenic factors such as basic fibroblast growth factor and platelet derived growth factor, which possibly lead to impaired implantation of the embryo. Furthermore, their mechanical presence may alter gamete transport via changes in uterine contractility. Inflammatory and fibrotic changes in the endometrium are also implicated in the increased risk of pregnancy loss. 94 Treatment for submucosal and intracavitary fibroids is based on the presence of symptoms and plans for future childbearing. 90 The traditional approach for fibroids was hyste rectomy; however, hysteroscopic myomectomy is recom mended for women who wish to conceive. 95 For those undergoing IVFET, the presence of submucosal and intra cavitary fibroids decreases chances of success. 96 At the moment there is insufficient evidence to support that removal increases IVFET outcome.
Case 10: Endometrial Polyp
Endometrial polyps are hyperplastic masses that originate from the endometrium. They are a common cause of abnormal uterine bleeding in both premenopausal and post meno pausal women. Though most endometrial polyps are benign, some express oncogenic potential. 97 They are also implicated in subfertility and infertility. Our patient noted an abnormal bleeding pattern which should prompt evaluation.
(12%33%). 82 Arcuate uterus is a much less severe variant that has a small midline septum with minimal fundal cavity indentation. 83 Xray hysterosalpingography allows excellent visuali zation of the uterine cavity outline; however disadvantages include timing (must be done in follicular phase), use of contrast, exposure to radiation, and lack of delineation of external uterine contour. 84 MRI is useful in detecting complex anomalies but it is not routinely used in gynecological evaluation due to the advent of other less costly approaches. Twodimensional transvaginal ultrasonography has relatively low accuracy but can be used as a screening tool. Bmode ultra sound depicts septate uterus as two endometrial echoes in the uterine cavity. Color Doppler can be used to determine the presence of vascularization in the septum, which has been correlated with pregnancy loss. 12 Saline infusion sono hysterography (SIS) is another method of visualizing the intrauterine space and structures however, like Xray HSG, it is invasive and does not illustrate the external fundal contour.
Threedimensional transvaginal ultrasonography has a diagnostic accuracy equal to hysteroscopic laparoscopy in diagnosing septate uterus as it depicts the uterine cavity, myo metrium and external uterine contour. 85, 86 By 3D ultrasound septate uterus is demonstrated as a partial or full midline divi sion between the two uterine horns, which creates a concave shape of the uterine fundus (see Fig. 8 ). The septum length and rate of uterine distortion can help predict the risk of obstetrical complications. 87 The diagnostic accuracy and low cost make 3D ultrasound an excellent screening and diagnostic tool for detection of uterine anomalies. Hysteroscopy and laparoscopy allow for direct visuali zation of the intrauterine and abdominal cavity and are therefore considered the gold standard for diagnosis and treat ment. Resection of the septum via hysteroscopy or hyste roscopic metroplasty have shown to improve pregnancy outcomes substantially. Leiomyomas are benign tumors of the uterus composed of smooth muscle and connective tissue; they can occur at various locations in the uterus: subserosal, intramural, sub mucosal and cervical. Approximately 25% of women with fibroids are symptomatic and present with varying degrees of pelvic pain and menorrhagia (heavy menstrual bleeding). 89 Submucosal and/or intracavitary fibroids are the type most commonly implicated in infertility; their location causes a distortion of the endometrial cavity possibly leading to impaired implantation and/or uterine contractility. 90 Our patient's heavy menstrual bleeding, previous miscarriage, Transvaginal ultrasound is the preferred initial diagnostic study for assessment of women with abnormal uterine bleeding. For further evaluation of morphology, saline infusion sonography (SIS) and/or diagnostic hysteroscopy are recommended. Saline infusion sonography is superior to the other diagnostic tools when a clinician needs to differentiate between focal and diffuse endometrial thick ening. 98 The presence of intracavitary fluid allows for better visualization of the intracavitary lesions, such as endo metrial polyp. 12 Saline infusion sonography will demonstrate hyperechogenic endometrial thickening in a focal area (see Fig. 10 ). Addition of color Doppler may show a solitary feeding vessel. Endometrial polyps may be difficult to differentiate from intracavitary fibroids; however a few sonographic characteristics can assist in making a final diagnosis. The presence of a single vessel, an acute angle, homogeneous echogenicity and intact endometrial myometrial interface in the lesion significantly increases the likelihood of endometrial polyp. 99 Due to her husband's diagnosis of oligoasthenozoospermia, our patient must undergo IVFET to achieve a potentially successful pregnancy. However, her abnormal uterine bleeding and subsequent discovery of endometrial polyp on ultrasound can decrease chances of success. Similar to submucosal and intracavitary leiomyomas, polyps can cause recurrent failure of embryo transplantation. 100 Hysteroscopic resection of endometrial polyps is effective in improving pregnancy rates (63% vs 28%). Polypectomy is beneficial for both spontaneous pregnancies and those from assisted reproductive technology (ART). 101 It is recommended for our patient to undergo removal of the endometrial polyp to increase chances of IVFET success. 
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